Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
European Review for Medical and Pharmacological Sciences|July 25, 2020
Artificial intelligence: a disruptive tool for a smarter medicineC M Galmarini, M LuciusDrugs of Today (Barcelona, Spain : 1998)|November 16, 2010
Cabazitaxel, a new taxane with favorable propertiesB P Bouchet, C M GalmariniCurrent Drug Targets|July 18, 2003
Drug resistance to cytotoxic nucleoside analoguesL Jordheim, C M Galmarini, C DumontetCurrent Cancer Drug Targets|January 29, 2008
Tubulin folding pathways: implication in the regulation of microtubule dynamicsA Beghin, C M Galmarini, C DumontetCurrent Medicinal Chemistry|May 14, 2008
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacyC M Galmarini, F Popowycz, B JosephLeukemia|June 22, 2001
Nucleoside analogues: mechanisms of drug resistance and reversal strategiesC M Galmarini, J R Mackey, C DumontetThe Orthopedic Clinics of North America|November 20, 2021
Necrotizing Soft Tissue Infections of the Hand and WristM Lucius PomerantzBritish Journal of Cancer|April 24, 2014
Trabectedin, a drug acting on both cancer cells and the tumour microenvironmentM D'Incalci, N Badri, C M Galmarini, et al.American Journal of Clinical Oncology|April 11, 2002
Clinical outcome and prognosis of patients with inflammatory breast cancerC M Galmarini, C Garbovesky, D Galmarini, et al.Medical Oncology (Northwood, London, England)|January 7, 2003
Oral ftorafur plus intramuscular thiotepa as adjuvant chemotherapy in patients with breast cancerC M Galmarini, C Garbovesky, D Galmarini, et al.Pageof 3